The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Belgian researchers explore revolutionary approach to angiogenesis

Geneva, Switzerland: A revolutionary approach to angiogenesis[1] by a team of Belgian researchers could make cancer treatment more effective at killing tumours.

Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.

The potential for exploiting tumour blood vessels has been made possible by their discovery in a study in mice that the arterioles (blood vessels less than 0.5mm in diameter) that feed tumours have the ability to contract in response to increases in pressure within their lumen (the space within the blood vessels). Equivalent sized blood vessels in healthy tissue can't do this.

"What this means is that we may have the potential to use drugs to selectively exploit these blood vessels against the tumour instead of, or before, killing them. Exploiting tumour blood vessels instead of destroying them by anti-angiogenic drugs constitutes a paradigm shift in approach to angiogenesis," Dr. Feron told a news briefing today (Thursday 30 September) at the EORTC-NCI-AACR[2] Symposium on Molecular Targets and Cancer Therapeutics.

The key to the ability of tumour arterioles to contract lies with endothelin-1 (ET-1) a peptide released in large amounts by many tumour cells, which stimulates their proliferation.

"The effect of ET-1 in tumours has been underestimated up to now," Dr. Feron said. "ET-1 has been known for years in cardiology as a very potent blood vessel constrictor. Here, we found that the myogenic tone (mechanical force) with which the tumour blood vessels contract and expand is exquisitely dependent on the endothelin pathway.

"What we did was to us
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
41-227-612-211
European Organisation for Research and Treatment of Cancer
30-Sep-2004


Page: 1 2

Related biology news :

1. Award winning researchers reveal potential new role for Glivec
2. $7.5 Million grant to Yale researchers for role of viruses in cancer
3. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
4. Joslin researchers clarify mechanisms for beta-cell formation
5. Virginia Tech researchers to release findings on Smith River Project
6. Molecular motor myosin VI moves hand over hand, researchers say
7. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
8. Emory researchers map structure of anti-cancer molecule
9. Leukemia stem cells identified by Stanford researchers
10. EURYI Award given for the first time to 25 young European researchers
11. Carnegie Mellon researchers to demonstrate autonomous robotthat will seek life in Atacama Desert

Post Your Comments:
(Date:11/20/2009)...sts from the Marine Biogeochemistry and Geology an...tory (NRL) organized and led a team of university ...to initiate methane hydrate exploration in the Bea...ediment contribution to Arctic climate change. , ...s a research platform, three cross-shelf transects...
(Date:11/20/2009)...he estimated 4.6 million Americans involved in the...iratory symptoms due to poor air quality in horse ...en earlier this year by investigators at Tufts Uni..., The studywhich polled more than 80 New England...duals working in barns complained of coughing, whe...
(Date:11/20/2009)...l gene into yeast, researchers from Delft Universi... improvements in bioethanol production from agricu... and elimination of the major by-product glycerol,...ntific journal Applied and Environmental Microbio...e yeast Saccharomyces cerevisiae from sugars obtai...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Delft breakthrough in bioethanol production from agricultural waste 2Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 1Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 2Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 3Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 4Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 5Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 6Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 7Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 8Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 9Orexigen 28R 29 Therapeutics Announces Second Quarter 2009 Financial Results 53898 10Osteotech to Present at the Canaccord Adams 29th Annual Global Growth Conference 53893 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 15
(Date:11/18/2009)..., Calif., Nov. 18 Sangam...ay that data from the University of Pennsylvania i...amo,s zinc finger nuclease (ZFN) based product, SB...urely disclosed on the internet. ,, Data were p...Pennsylvania School of Medicine from a single subj...
(Date:11/18/2009)...alif., Nov. 18 Masimo ...y(TM) and Measure-Through Motion and Low-Perfusion...-based Uni.H.A., one of the largest healthcare Gro...igned a multi-year purchasing agreement for "gold ... agreement offers preferred contract pricing to Un...
(Date:11/18/2009)...YORK, Nov. 18 Reportlinker.com ann...ble in its catalogue. ,, Biotechnology Reagen...www.reportlinker.com/p0164375/Biotechnology-Reagen...rnewswire&utm_medium=pr&utm_campaign=prnew...omplex chemical compounds used in a range of biote...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics ...tein interactions. , Madi...Corporation and SwitchGear Genomics announce a nov...ons. Results of a study using the HaloCHIP™ ...rate the ability to correlate DNA binding events t...
Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
Other News:
...per and wood -- they're all made of the cellulose ...surprisingly, scientists do not know a lot about h... the University of California, Davis, has shed lig...tosterol, a fatty substance similar to cholesterol...
...se is also available in Spanish.......Fluorescent ...But, the glowing look is always alluring if you're...ingdom and Australia. ......New findings on parrot...of the international journal, Science, published b...
Biodiversity recovers more slowly than thought...... The 500-million-year history of life on Earth is a series of...booms and busts. But while the busts, or extinctions, can be...either sudden o
... Md. --A first strain of bacterium that breaks dow...chlorinated biphenyls, in estuarine sediment is re...mental Microbiology by scientists with the Univers...iments repeated many times on bottom sediments fro...
Evolutionary 'speed limit' governs how quickly life bounces back after extinction 2Microbe first to break down PCBs 2
...ses and issues that are significantly affecting Ca...t a news conference to be held Monday, July 30, 20...d during the joint meeting of The American Phytopa...logists (SON) in San Diego, California. ... Leadin...
...ion Agency (EPA) have an adequate strategy to ensu...zed? Can it get needed information through a propo...ails about the nature of the nanomaterials they ar...eps to ensure safety? What incentives, if any, exi...
...esearchers from the University of Colorado Health ...rd University, report the results of a large-scale...r differences among ten primate species, including...and gene families that have undergone major copy n...
... in on the main genetic pathway associated with mu...enetic variations in the disease and suggesting a ...ases.... The first study, led by an international ...erts, incorporates the two largest collections of ...
Genomics study provides insight into the evolution of unique human traits 2Research teams uncover risk genes for multiple sclerosis 2Research teams uncover risk genes for multiple sclerosis 3Research teams uncover risk genes for multiple sclerosis 4